Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS

Summary

The primary objective of this randomized controlled clinical trial in a real life setting is to evaluate the cost-utility of limumab monotherapy compared with the combination of adalimumab and a maximum of three surgeries after two years of treatment in adult patients with moderate to severe HS.

Timeline

Start

2018-07-31

Primary completion

2022-07-31

Completion

2022-07-31

Drugs

Indications